Literature DB >> 12391292

Control of lactotrop proliferation by dopamine: essential role of signaling through D2 receptors and ERKs.

Ciro Iaccarino1, Tarek A Samad, Carole Mathis, Henri Kercret, Roberto Picetti, Emiliana Borrelli.   

Abstract

Dopamine is thought to exert a negative control on lactotrop cell proliferation and prolactin production. Indeed, mice lacking the D2 receptor develop pituitary tumors of lactotrop origin. Because lactotrops express two isoforms of D2R, D2L, and D2S, in a specific ratio, we decided to explore the physiological importance of their relative abundance in vivo. Thus, we generated transgenic animals overexpressing either D2L or D2S in lactotrops. Increased expression of D2S, but not of D2L, leads to mitogen-activated protein kinase (MAPK) induction, which results in pituitary hypoplasia. On the other hand, levels of phosphorylated MAPKs are drastically reduced in pituitary tumors generated by the absence of D2-dependent signaling. These results underline a critical role of D2-mediated MAPK activation in lactotrop proliferation. Furthermore, whereas D2S overexpression results to a drastic reduction of prolactin, D2L overexpression elevates it. Our findings underscore a different role of the two D2R isoforms in the pituitary gland physiology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12391292      PMCID: PMC137917          DOI: 10.1073/pnas.222319599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Differential expression of the mouse D2 dopamine receptor isoforms.

Authors:  J P Montmayeur; P Bausero; N Amlaiky; L Maroteaux; R Hen; E Borrelli
Journal:  FEBS Lett       Date:  1991-01-28       Impact factor: 4.124

2.  Alternative splicing directs the expression of two D2 dopamine receptor isoforms.

Authors:  B Giros; P Sokoloff; M P Martres; J F Riou; L J Emorine; J C Schwartz
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

3.  Multiple D2 dopamine receptors produced by alternative RNA splicing.

Authors:  F J Monsma; L D McVittie; C R Gerfen; L C Mahan; D R Sibley
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

4.  Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice.

Authors:  S L Asa; M A Kelly; D K Grandy; M J Low
Journal:  Endocrinology       Date:  1999-11       Impact factor: 4.736

5.  Characterization of the MMQ cell, a prolactin-secreting clonal cell line that is responsive to dopamine.

Authors:  A M Judd; I S Login; K Kovacs; P C Ross; B L Spangelo; W D Jarvis; R M MacLeod
Journal:  Endocrinology       Date:  1988-11       Impact factor: 4.736

Review 6.  Analysis of gene expression using simian virus 40 vectors.

Authors:  S Subramani; P J Southern
Journal:  Anal Biochem       Date:  1983-11       Impact factor: 3.365

7.  Dwarf mice produced by genetic ablation of growth hormone-expressing cells.

Authors:  R R Behringer; L S Mathews; R D Palmiter; R L Brinster
Journal:  Genes Dev       Date:  1988-04       Impact factor: 11.361

8.  Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study.

Authors:  M E Molitch; R L Elton; R E Blackwell; B Caldwell; R J Chang; R Jaffe; G Joplin; R J Robbins; J Tyson; M O Thorner
Journal:  J Clin Endocrinol Metab       Date:  1985-04       Impact factor: 5.958

9.  Inhibitory control of prolactin and Pit-1 gene promoters by dopamine. Dual signaling pathways required for D2 receptor-regulated expression of the prolactin gene.

Authors:  H P Elsholtz; A M Lew; P R Albert; V C Sundmark
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

10.  The dopamine D2 receptor: two molecular forms generated by alternative splicing.

Authors:  R Dal Toso; B Sommer; M Ewert; A Herb; D B Pritchett; A Bach; B D Shivers; P H Seeburg
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  35 in total

1.  Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK:BMAL1.

Authors:  Irene Yujnovsky; Jun Hirayama; Masao Doi; Emiliana Borrelli; Paolo Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-10       Impact factor: 11.205

2.  Dopamine, dopamine D2 receptor short isoform, transforming growth factor (TGF)-beta1, and TGF-beta type II receptor interact to inhibit the growth of pituitary lactotropes.

Authors:  D K Sarkar; K Chaturvedi; S Oomizu; N I Boyadjieva; C P Chen
Journal:  Endocrinology       Date:  2005-06-16       Impact factor: 4.736

Review 3.  Pharmacologic resistance in prolactinoma patients.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

4.  Nerve growth factor, D2 receptor isoforms, and pituitary tumors.

Authors:  Cristina Missale
Journal:  Endocrine       Date:  2012-12       Impact factor: 3.633

Review 5.  Genesis of prolactinomas: studies using estrogen-treated animals.

Authors:  Dipak K Sarkar
Journal:  Front Horm Res       Date:  2006       Impact factor: 2.606

6.  Comparison of the temporal programs regulating tyrosine hydroxylase and enkephalin expressions in TIDA neurons of lactating rats following pup removal and then pup return.

Authors:  Flora Klara Szabó; Wei-Wei Le; Natalie S Snyder; Gloria E Hoffman
Journal:  J Mol Neurosci       Date:  2010-12-02       Impact factor: 3.444

7.  The Balance of PI3K and ERK Signaling Is Dysregulated in Prolactinoma and Modulated by Dopamine.

Authors:  Allyson K Roof; Siwanon Jirawatnotai; Tammy Trudeau; Crystal Kuzyk; Margaret E Wierman; Hiroaki Kiyokawa; Arthur Gutierrez-Hartmann
Journal:  Endocrinology       Date:  2018-06-01       Impact factor: 4.736

8.  Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells.

Authors:  Matthew Miller; Shenglin Chen; Jeffrey Woodliff; Sanjay Kansra
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

9.  Cleft palate is caused by CNS dysfunction in Gad1 and Viaat knockout mice.

Authors:  Won-Jong Oh; Joby J Westmoreland; Ryan Summers; Brian G Condie
Journal:  PLoS One       Date:  2010-03-19       Impact factor: 3.240

Review 10.  Dopamine resistance of prolactinomas.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.